| scholarly article | Q13442814 |
| P2093 | author name string | Grau GE | |
| Pechère JC | |||
| Chang HR | |||
| P2860 | cites work | A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection | Q24654068 |
| Secretory products of macrophages | Q34557411 | ||
| Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors | Q36353257 | ||
| Cachectin and tumour necrosis factor as two sides of the same biological coin | Q39501245 | ||
| Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities | Q39507424 | ||
| Interleukin-1. | Q40173633 | ||
| An investigation of the antigenic structure of Toxoplasma gondii | Q41476337 | ||
| Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria | Q45078080 | ||
| Interferon-gamma: the major mediator of resistance against Toxoplasma gondii | Q45128276 | ||
| Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole | Q47908442 | ||
| In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii | Q48432462 | ||
| In-vitro toxoplasmacidal activity of cationic electron carriers. | Q50890293 | ||
| Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. | Q53956320 | ||
| Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. | Q54380601 | ||
| Strain differences of interferon-generating capacity and resistance in toxoplasma-infected mice. | Q54439049 | ||
| Purification and physico-chemical characterization of rabbit tumor necrosis factor. | Q54547513 | ||
| Purification and characterization of human interleukin-1 alpha produced in Escherichia coli. | Q54764206 | ||
| Toxoplasmosis: the time has come | Q68251755 | ||
| Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi | Q68890417 | ||
| Production of tumor necrosis factor during murine listeriosis | Q69474471 | ||
| Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential | Q69927093 | ||
| Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production | Q70405593 | ||
| Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages | Q70411572 | ||
| Effect of murine interferon gamma on murine toxoplasmosis | Q70507351 | ||
| Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma) | Q80912304 | ||
| P433 | issue | 1 | |
| P921 | main subject | Toxoplasma gondii | Q131003 |
| P304 | page(s) | 33-37 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Role of TNF and IL-1 in infections with Toxoplasma gondii | |
| P478 | volume | 69 |
| Q36945212 | A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection |
| Q41110465 | A study on the status of inflammatory systems in camels naturally infected with Toxoplasma gondii |
| Q98177694 | C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection |
| Q72864840 | Co-operation of interleukin-1 beta and tumour necrosis factor-alpha in the activation of human umbilical vein endothelial cells to inhibit Toxoplasma gondii replication |
| Q33606893 | Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence |
| Q38215371 | Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection |
| Q33609623 | Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. |
| Q35474667 | Different roles for interleukin-4 during the course of Toxoplasma gondii infection |
| Q37621648 | Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii |
| Q36972580 | Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice |
| Q70670444 | Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice |
| Q35763523 | Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. |
| Q35773520 | Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii |
| Q36994369 | Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15. |
| Q24612341 | Immune response and immunopathology during toxoplasmosis |
| Q37114104 | Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections |
| Q36942596 | Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection |
| Q40439491 | In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis |
| Q34527995 | Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages |
| Q40254628 | Infection-stimulated anemia results primarily from interferon gamma-dependent, signal transducer and activator of transcription 1-independent red cell loss |
| Q38181331 | Innate immunity to Toxoplasma gondii infection |
| Q91890897 | Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection |
| Q36357440 | Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants |
| Q35524566 | Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells |
| Q67984891 | Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria |
| Q37577380 | Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly |
| Q58799404 | Mutual interactions of the apicomplexan parasites Toxoplasma gondii and Eimeria tenella with cultured poultry macrophages |
| Q35436281 | Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alpha and interleukin 6, reactive nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages |
| Q40048102 | NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during Toxoplasma gondii Infection. |
| Q33958822 | Neurological disorders and inflammatory bowel diseases |
| Q35124789 | Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats |
| Q38958188 | Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani |
| Q36952794 | Recombinant interleukin-6 protects mice against experimental bacterial infection |
| Q33975360 | Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. |
| Q59813501 | Risk Assessment of Etanercept in Mice Chronically Infected With |
| Q37346988 | Role of gamma interferon in Toxoplasma gondii infection |
| Q35512225 | Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila |
| Q40147154 | Sera of patients with high titers of immunoglobulin G against Toxoplasma gondii induce secretion of tumor necrosis factor alpha by human monocytes |
| Q37333399 | Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines |
| Q91624604 | The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-κB signalling via EZH2 |
| Q33867213 | The meteorology of cytokine storms, and the clinical usefulness of this knowledge |
| Q37784863 | The roles of TNF in brain dysfunction and disease |
| Q35820994 | The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia |
| Q35771619 | Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. |
| Q92867371 | Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin D-independent release of IL-1β during infection of primary human monocytes |
| Q34534147 | Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages. |
| Q33752033 | Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice |
| Q35778238 | Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. |
Search more.